Predictors of dropout from psychosocial treatment in opioid-dependent outpatients

American Journal on Addictions

Volumn 22, Issue 1, 2013, Pages 18-22

  McHugh, R Kathryn ^a,b   Murray, Heather W ^c   Hearon, Bridget A ^c   Pratt, Elizabeth M ^c   Pollack, Mark H ^d   Safren, Steven A ^b,e   Otto, Michael W ^c  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BOSTON UNIVERSITY   (United States)

^d RUSH UNIVERSITY MEDICAL CENTER   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; METHADONE;

ADULT; ANXIETY SENSITIVITY INDEX; ARTICLE; COPING BEHAVIOR; COUNSELING; DRUG USE; EDUCATION; ETHNICITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; MOTIVATION; OPIATE ADDICTION; OUTPATIENT; RACE; RISK FACTOR; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; TREATMENT WITHDRAWAL;

ADULT; AGE FACTORS; FEMALE; HUMANS; MALE; OPIOID-RELATED DISORDERS; OUTPATIENTS; PATIENT DROPOUTS; PSYCHOTHERAPY; RISK FACTORS;

EID: 84873642632     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1111/j.1521-0391.2013.00317.x     Document Type: Article

References (33)

1. Salamina G, Diecidue R, Vigna-Taglianti F, et al. Effectiveness of therapies for heroin addiction in retaining patients in treatment: Results from the VEdeTTE study. Subst Use Misuse. 2010; 45: 2076-2092.
2. Nosyk B, Geller J, Guh DP, et al. The effect of motivational status on treatment outcome in the North American Opiate Medication Initiative (NAOMI) study. Drug Alcohol Depend. 2010; 111: 161-165.
3. Simpson DD, Joe GW, Broome KM., A national 5-year follow-up of treatment outcomes for cocaine dependence. Arch Gen Psychiatry. 2002; 59: 538-544.
4. Simpson DD, Joe GW, Fletcher BW, et al. A national evaluation of treatment outcomes for cocaine dependence. Arch Gen Psychiatry. 1999; 56: 507-514.
5. Zhang Z, Friedmann PD, Gerstein DR., Does retention matter? Treatment duration and improvement in drug use. Addiction. 2003; 98: 673-684.
6. Graff FS, Morgan TJ, Epstein EE, et al. Engagement and retention in outpatient alcoholism treatment for women. Am J Addict. 2009; 18: 277-288.
7. Mulder RT, Frampton CM, Peka H, et al. Predictors of 3-month retention in a drug treatment therapeutic community. Drug Alcohol Rev. 2009; 28: 366-371.
8. Curran GM, Stecker T, Han X, et al. Individual and program predictors of attrition from VA substance use treatment. J Behav Health Serv Res. 2009; 36: 25-34.
9. Pagnin D, de Queiroz V, Saggese EG., Predictors of attrition from day treatment of adolescents with substance-related disorders. Addict Behav. 2005; 30: 1065-1069.
10. Che Y, Assanangkornchai S, McNeil E, et al. Patterns of attendance in methadone maintenance treatment program in Yunnan Province, China. Am J Drug Alcohol Abuse. 2011; 37: 148-154.
11. Peles E, Schreiber S, Adelson M., Factors predicting retention in treatment: 10-Year experience of a methadone maintenance treatment (MMT) clinic in Israel. Drug Alcohol Depend. 2006; 82: 211-217.
12. Rothenberg JL, Sullivan MA, Church SH, et al. Behavioral naltrexone therapy: An integrated treatment for opiate dependence. J Subst Abuse Treat. 2002; 23: 351-360.
13. Sullivan MA, Rothenberg JL, Vosburg SK, et al. Predictors of retention in naltrexone maintenance for opioid dependence: Analysis of a stage I trial. Am J Addict. 2006; 15: 150-159.
14. Lejuez CW, Zvolensky MJ, Daughters SB, et al. Anxiety sensitivity: A unique predictor of dropout among inner-city heroin and crack/cocaine users in residential substance use treatment. Behav Res Ther. 2008; 46: 811-818.
15. O'Cleirigh C, Ironson G, Smits JA., Does distress tolerance moderate the impact of major life events on psychosocial variables and behaviors important in the management of HIV ? Behav Ther. 2007; 38: 314-323.
16. Brandon TH, Herzog TA, Juliano LM, et al. Pretreatment task persistence predicts smoking cessation outcome. J Abnorm Psychol. 2003; 112: 448-456.
17. Daughters SB, Lejuez CW, Kahler CW, et al. Psychological distress tolerance and duration of most recent abstinence attempt among residential treatment-seeking substance abusers. Psychol Addict Behav. 2005; 19: 208-211.
18. McHugh RK, Hearon BA, Halperin DM, et al. A novel method for assessing distress intolerance: Adaptation of a measure of willingness to pay. J Behav Ther Exp Psychiatry. 2011; 42: 440-446.
19. Daughters SB, Lejuez CW, Bornovalova MA, et al. Distress tolerance as a predictor of early treatment dropout in a residential substance abuse treatment facility. J Abnorm Psychol. 2005; 114: 729-734.
20. Epstein DH, Willner-Reid J, Vahabzadeh M, et al. Real-time electronic diary reports of cue exposure and mood in the hours before cocaine and heroin craving and use. Arch Gen Psychiatry. 2009; 66: 88-94.
21. Brands B, Blake J, Marsh DC, et al. The impact of benzodiazepine use on methadone maintenance treatment outcomes. J Addict Dis. 2008; 27: 37-48.
22. Schaub M, Stevens A, Haug S, et al. Predictors of retention in the 'voluntary' and 'quasi-compulsory' treatment of substance dependence in Europe. Eur Addict Res. 2011; 17: 97-105.
23. Davstad I, Stenbacka M, Leifman A, et al. Patterns of illicit drug use and retention in a methadone program: A longitudinal study. J Opioid Manag. 2007; 3: 27-34.
24. Kissin WB, Svikis DS, Moylan P, et al. Identifying pregnant women at risk for early attrition from substance abuse treatment. J Subst Abuse Treat. 2004; 27: 31-38.
25. Kenne DR, Boros AP, Fischbein RL., Characteristics of opiate users leaving detoxification treatment against medical advice. J Addict Dis. 2010; 29: 383-394.
26. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders: Patient Edition. New York, NY: New York State Psychiatric Institute; 1996.
27. McLellan AT, Kushner H, Metzger D, et al. The fifth edition of the Addiction Severity Index. J Subst Abuse Treat. 1992; 9: 199-213.
28. McLellan AT, Cacciola JC, Alterman AI, et al. The Addiction Severity Index at 25: Origins, contributions and transitions. Am J Addict. 2006; 15: 113-124.
29. Mueser KT, Nishith P, Tracy JI, et al. Expectations and motives for substance use in schizophrenia. Schizophr Bull. 1995; 21: 367-378.
30. Cooper M, Russell M, Skinner J, et al. Development and validation of a three-dimensional measure of drinking motives. Psychol Assess. 1992; 4: 123-132.
31. Peterson RA, Reiss S., Anxiety Sensitivity Index Revised Manual. Worthington, OH: International Diagnostic Systems Publishing Corportation; 1992.
32. Reiss S, Peterson RA, Gursky DM, et al. Anxiety sensitivity, anxiety frequency and the predictions of fearfulness. Behav Res Ther. 1986; 24: 1-8.
33. Mancino M, Curran G, Han X, et al. Predictors of attrition from a national sample of methadone maintenance patients. Am J Drug Alcohol Abuse. 2010; 36: 155-160.